By PPN News Staff
A daily dose of buprenorphine-naloxone is more cost-effective than monthly injections of extended-release naltrexone for treating opioid use disorder. The two medications were similarly effective in terms of quality of life and time abstaining from opioids (Ann Intern Med 2018 Dec 18. [Epub ahead of print]).
The FDA approved three medications for first-line treatment of opioid use disorder. Methadone is available only in strictly regulated clinics, but buprenorphine and